Информация для врачей
Исследования

  • Jodai A., Maaita N., Shimomae E. et al. A long-term therapeutic experience with Cernilton in chronic prostatitis //Hinyo Kiyo. - 1988. - Vol. 34. - P.561-568.
  • Buck A.C., Cox R., Rees W.M., Ebeling L., and John A. Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, Cernilton®. A double-blind, placebo-controlled study", Br. J. Urol. 66:398-404. 1990
  • Yasumoto R., Kawanishi H., Tsujino T., et al. Clinical evaluation of long-term treatment using Cernilton® pollen extract in patients with benign prostatic hyperplasia", Clin Ther 17:82-87, 1995
  • Becker H., and Ebeling L. "Conservative treatment of benign prostatic hyperplasia (BPH) with Cernilton. Results of a placebo-controlled double-blind study", Urologe (b) 28:301-306, 1988
  • Dutkiewicz S. "Usefulness of Cernilton in the treatment of benign prostatic hyperplasia", Int Urol. Nephrol. 28:49-53, 1996
  • Jacobsen S.J., Guess H.A., Panser L., Girman C.J., Chute C.G., Oesterling J.E. et al. A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County Study of Urinary Symptoms and Health Status Among Men. Arch. Fam. Med., 1993;2:729.
  • Wenninger K., Heiman J.R., Rothman I. et al. Sickness impact of chronic nonbacterial prostatitis and its correlates. J. Urol., 1996;155:965-968.
  • Verhamme K.M., Dieleman J.P., Bleumink G.S., van der Lei J., Sturkenboom M.C., Artibani W., Begaud B., Berges R., Borkowski A., Chappel C.R., Costello A., Dobronski P., Farmer R.D., Jimenez Cruz F., Jonas U., MacRae K., Pientka L., Rutten F.F., van Schayck C.P., Speakman M.J., Sturkenboom M.C., Tiellac P., Tubaro A., Vallencien G., Vela Navarrete R. Triumph Pan European Expert Panel. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project. Eur Urol. 2002 Oct;42(4):323-8.
  • Krieger J.N. Classification, epidemiology and implications of chronic prostatitis in North America, Europe and Asia. Minerva Urol Nefrol. 2004 Jun;56(2):99-107.
  • Shoskes D.A., Manickam K. Herbal and complementary medicine in chronic prostatitis. World J. Urol. 2003 Jun;21(2):109-13.
    McNicholas T.A. Lower urinary tract symptoms suggestive of benign prostatic obstruction: what are the current practice patterns? Eur Urol. 2001;39 Suppl 3:26-30.
  • Wilt T., Mac Donald R., Ishani A., Rutks I., Stark G. Cernilton for benign prostatic hyperplasia. Cochrane Database Syst. Rev., 2000;(2):CD001042.
  • Buck A.C. Phytotherapy for the prostate. Br J Urol 1996; 78:325-326.
  • Meares Jr. EM. Prostatitis and related disorders. In: Campbell's Urology, 6th edition. (ed) P.C. Walsh, Philadelphia, PA, 1992, p. 807-822.
  • Preuss H.G., Adderly B. Benign prostatic hyperplasia: men's secret disease. In: The Prostate Cure. (eds.) H.G. Preuss, B. Adderly. Crown Publishing, Inc., New York, NY, 1998; p. 1-29.
  • Hanamoto M., Liao M., Suzuki H., et al. Effect of Cernitin pollen-extract on the Sex-hormone-induced Nonbacterial Prostatitis in Rats. Jpn. Pharmacol. Ther., 1998;11:65.
  • Ito R., Ishii M, Yamashita S. et al. Antiprostatic hypertrophic action of Cernilton pollen-extract. Pharmacometrics, 1986;31:1-11.
  • Kimura M., Kimura I., Nakase K., Sonobe T., Mori E. Micturition activity of pollen extract: contractile effects on bladder and inhibitory effects on urethral smooth muscle of mouse and pig. Planta. Med., 1986; 2: 148-51.
  • Nakase S., Takenaka K., Hamanaka T., Kimura M. Effects of Cernilton pollen-extract on the urethral smooth muscle and diaphragmatic neuromuscular specimen. Folio Pharmacol. Japan, 1988;91:385-92.
  • Talpur N., Echard B., Bagchi D., Bagchi M., Preuss H.G. Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats. Mol Cell Biochem., 2003 Aug;250(1-2):21-26.
  • Loschen G., Ebeling L. Inhibition of arachidonic acid cascade by extract of rye pollen. Arzneimittelforschung. 1991 Feb;41(2):162-7.
  • MacDonald R., Ishani A., Rutks I., Wilt T.J. A systematic review of Cernilton for the treatment of benign prostatic hyperplasia. BJU Int. 2000 May;85(7):836-41.
  • Capodice J.L., Bemis D.L., Buttyan R., Kaplan S.A., Katz A.E. Complementary and alternative medicine for chronic prostatitis/chronic pelvic pain syndrome. Evid Based Complement Alternat Med. 2005 Dec;2(4):495-501.
Более подробную информацию по клиническим испытаниям Вы можете получить, обратившись в нашу компанию.

Публикации

Сертификаты

Made on
Tilda